Antimicrobial Resistance Diagnostic Market by Product Type, Testing Location, Facility Type - Global Forecast 2025-2030- Product Image

Sale

Antimicrobial Resistance Diagnostic Market by Product Type, Testing Location, Facility Type - Global Forecast 2025-2030

Report
184 Pages
October 2024
Region: Global
360iResearch™
ID: 6014956

UP TO €667EUR$697USD£557GBP OFF until Dec 31^st 2024

The Antimicrobial Resistance Diagnostic Market grew from USD 4.53 billion in 2023 to USD 4.75 billion in 2024. It is expected to continue growing at a CAGR of 6.14%, reaching USD 6.88 billion by 2030.

Antimicrobial resistance (AMR) diagnostics encompass technologies that detect resistance patterns in pathogens, crucial for managing infectious diseases. The necessity of these diagnostics arises from the increasing threat posed by multi-drug resistant organisms which undermine current treatment regimes, leading to higher mortality rates and healthcare costs. Applications extend to various healthcare settings, including hospitals and outpatient clinics, where rapid diagnostic testing is essential for prompt decision-making. End-use sectors include public health laboratories, biotechnology companies, and academic research institutions focused on developing new diagnostic tools and treatment strategies. Market growth is significantly influenced by rising incidences of drug-resistant infections, advancing research and development initiatives, and increasing government focus on combating AMR. Emerging technologies such as next-generation sequencing and AI-driven diagnostic tools present potential opportunities; companies that invest in these innovations can achieve competitive advantages. However, limitations include high costs of advanced diagnostics and a lack of standardized regulations, which can impede market penetration. Challenging factors encompass the slower pace of approval from regulatory bodies and limited access to healthcare infrastructure in developing regions. For businesses aiming for growth, research should focus on cost-effective, rapid, and scalable diagnostic solutions that can be easily integrated into existing healthcare systems. Innovations in point-of-care testing and personalized treatment plans tailored by genetic profiling stand out as promising areas. The market is highly dynamic, driven by both technological advancements and urgent global health needs, presenting ample opportunities for companies that can overcome these challenges. Strategic partnerships and collaborations with public health organizations and technology firms are recommended to extend market outreach and navigate regulatory landscapes efficiently. Overall, while the AMR diagnostics market is poised for growth, success hinges on continuous innovation and strategic adaptation to evolving healthcare environments.

Understanding Market Dynamics in the Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of antimicrobial resistance leading to a higher demand for diagnostic solutions
- Government initiatives and funding to combat antimicrobial resistance through improved diagnostics
- Growing awareness among healthcare professionals and public about the importance of early and accurate antimicrobial resistance diagnosis
Market Restraints
- High cost associated with advanced diagnostic tests
Market Opportunities
- Cross-sector partnerships to combat antimicrobial resistance using comprehensive diagnostic approaches
- Investment opportunities in startups focused on antimicrobial resistance diagnostic innovations
Market Challenges
- Lack of standardization protocol and regulatory harmonization across various region

Exploring Porter’s Five Forces for the Antimicrobial Resistance Diagnostic Market

Porter’s Five Forces framework further strengthens the insights of the Antimicrobial Resistance Diagnostic Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Antimicrobial Resistance Diagnostic Market

External macro-environmental factors deeply influence the performance of the Antimicrobial Resistance Diagnostic Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Antimicrobial Resistance Diagnostic Market

The Antimicrobial Resistance Diagnostic Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Resistance Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Beckman Coulter, Becton, Dickinson and Company, BioFire Diagnostics, bioMérieux, Bruker Corporation, Cardinal Health, Cepheid, GenMark Diagnostics, GSK plc, Hoffmann-La Roche, Hologic, Inc., Luminex Corporation, Merck & Co., Inc., OpGen, Qiagen, Siemens Healthineers, T2 Biosystems, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Resistance Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Assays & Reagents
  - Biosensors
  - Monoclonal Anitbodies
- Diagnostic Tools
  - Instruments
  - Software & Services
Testing Location
- Laboratory Testing
  - Isothermal Nucleic Acid Amplification Technology (INAAT)
  - Polymerase Chain Reaction (PCR)
- Point-Of-Care Testing
  - Immunoassays
  - Microarray
Facility Type
- End User
  - Diagnostic Laboratories
  - Hospitals And Clinics
- Research
  - CROs
  - Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of antimicrobial resistance leading to a higher demand for diagnostic solutions
5.1.1.2. Government initiatives and funding to combat antimicrobial resistance through improved diagnostics
5.1.1.3. Growing awareness among healthcare professionals and public about the importance of early and accurate antimicrobial resistance diagnosis
5.1.2. Restraints
5.1.2.1. High cost associated with advanced diagnostic tests
5.1.3. Opportunities
5.1.3.1. Cross-sector partnerships to combat antimicrobial resistance using comprehensive diagnostic approaches
5.1.3.2. Investment opportunities in startups focused on antimicrobial resistance diagnostic innovations
5.1.4. Challenges
5.1.4.1. Lack of standardization protocol and regulatory harmonization across various region
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Antimicrobial Resistance Diagnostic Market, by Product Type

6.1. Introduction
6.2. Assays & Reagents
6.2.1. Biosensors
6.2.2. Monoclonal Anitbodies
6.3. Diagnostic Tools
6.3.1. Instruments
6.3.2. Software & Services

7. Antimicrobial Resistance Diagnostic Market, by Testing Location

7.1. Introduction
7.2. Laboratory Testing
7.2.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.2.2. Polymerase Chain Reaction (PCR)
7.3. Point-Of-Care Testing
7.3.1. Immunoassays
7.3.2. Microarray

8. Antimicrobial Resistance Diagnostic Market, by Facility Type

8.1. Introduction
8.2. End User
8.2.1. Diagnostic Laboratories
8.2.2. Hospitals And Clinics
8.3. Research
8.3.1. CROs
8.3.2. Research Institutes

9. Americas Antimicrobial Resistance Diagnostic Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Antimicrobial Resistance Diagnostic Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Antimicrobial Resistance Diagnostic Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET DYNAMICS
TABLE 7. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MONOCLONAL ANITBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT), BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 62. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 64. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 65. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 67. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 68. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. CANADA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 109. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 111. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 112. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 113. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 114. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 115. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 116. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. CHINA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 118. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 120. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 121. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 122. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 123. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 124. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. INDIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 136. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 138. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 139. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 140. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 141. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 142. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 143. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. JAPAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 192. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 193. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 194. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 195. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 196. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 197. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. THAILAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 205. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 218. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 221. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 222. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 223. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 224. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 225. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. DENMARK ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 227. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 229. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 230. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 231. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 232. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 233. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 234. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. EGYPT ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 236. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 238. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 239. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 240. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 241. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 242. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 243. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. FINLAND ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 245. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 249. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 250. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 251. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 252. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. FRANCE ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 254. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 256. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 257. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 258. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 259. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 260. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 261. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. GERMANY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 272. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 274. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 275. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 276. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 277. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 278. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 279. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ITALY ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC TOOLS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY TESTING LOCATION, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKET SIZE, BY ASSAYS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA ANTIMICROBIAL RESISTANCE DIAGNOSTIC MAR

Companies Mentioned

The leading players in the Antimicrobial Resistance Diagnostic Market, which are profiled in this report, include:

Abbott Laboratories
Accelerate Diagnostics
Beckman Coulter
Becton, Dickinson and Company
BioFire Diagnostics
bioMérieux
Bruker Corporation
Cardinal Health
Cepheid
GenMark Diagnostics
GSK plc
Hoffmann-La Roche
Hologic, Inc.
Luminex Corporation
Merck & Co., Inc.
OpGen
Qiagen
Siemens Healthineers
T2 Biosystems
Thermo Fisher Scientific

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.75 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.88 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3395EUR$3,545USD£2,831GBP €3772EUR$3,939USD£3,145GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6006EUR$6,272USD£5,009GBP €6673EUR$6,969USD£5,565GBP

Understanding Market Dynamics in the Antimicrobial Resistance Diagnostic Market

Exploring Porter’s Five Forces for the Antimicrobial Resistance Diagnostic Market

Applying PESTLE Analysis to the Antimicrobial Resistance Diagnostic Market

Analyzing Market Share in the Antimicrobial Resistance Diagnostic Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antimicrobial Resistance Diagnostic Market

Strategic Recommendations for Success in the Antimicrobial Resistance Diagnostic Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbiology Culture, Immunoassay, PCR, NGS), By Pathogen, By End User, By Region, And Segment Forecasts, 2022 - 2030

Antimicrobial Resistance Surveillance Market by Component, End-User - Global Forecast 2025-2030

Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028

Antimicrobial Resistance Surveillance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals, Diagnostic Laboratories and Pharmaceutical, Biotechnology Companies), By Pathogen, By Regional Outlook and Forecast, 2022 - 2028